000 | 01250 a2200301 4500 | ||
---|---|---|---|
005 | 20250517163543.0 | ||
264 | 0 | _c20170907 | |
008 | 201709s 0 0 eng d | ||
022 | _a1879-0852 | ||
024 | 7 |
_a10.1016/j.ejca.2017.06.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoer, Judith M | |
245 | 0 | 0 |
_aBCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c09 2017 |
||
300 |
_a203-218 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntineoplastic Agents |
650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Cytokine _xmetabolism |
700 | 1 | _aden Boer, Monique L | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 82 _gp. 203-218 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2017.06.012 _zAvailable from publisher's website |
999 |
_c27369075 _d27369075 |